Haapalinna A, Leino T, Heinonen E (noviembre de 2003). «The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats». Naunyn Schmiedebergs Arch. Pharmacol.368 (5): 342-51. PMID14566451. doi:10.1007/s00210-003-0827-z.
nih.gov
ncbi.nlm.nih.gov
Haapalinna A, Leino T, Heinonen E (noviembre de 2003). «The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats». Naunyn Schmiedebergs Arch. Pharmacol.368 (5): 342-51. PMID14566451. doi:10.1007/s00210-003-0827-z.